Specializing in FDA Regulatory Matters

EAS Consulting Group, LLC (EAS) specializes in Food and Drug Administration (FDA) regulatory matters. Our prime focus is to assist domestic and foreign pharmaceutical, medical device, tobacco, food, dietary supplement, and cosmetic firms comply with applicable laws and regulations. EAS is staffed with former FDA compliance and inspection officials and industry executives, and is assisted by an extensive network of consultants with many years of FDA and industry experience.


Headquartered in Alexandria, VA with consultants and auditors located strategically throughout the U.S., EAS Consulting Group was established as an independent company in October 2006. Prior to that, it was a division of Kendle Regulatory Affairs (formerly known as AAC Consulting Group).

Recent Issue of the Month Articles

From FDA Ombudsman to EAS Consultant

Every Center in FDA, except CFSAN, has an Ombudsman; there is also an Ombudsman in the Office of the Commissioner. I am the only person to have served as the Ombudsman in two different Centers: the Center for Tobacco Products (CTP) for three years and the Center for Devices and Radiological Health (CDRH) for ten… Read More

FDA’s Generic Drug User Fee Act (GDUFA) – Drug Master Files (DMFs)

Two years have passed since passage of the Generic Drug User Fee Act (GDUFA). GDUFA is a significant law that introduced new requirements for active pharmaceutical ingredient (API) manufacturers, including fees associated with their Type II drug master files (DMFs), as well as for establishment registrations and for conversion of type II DMFs into Electronic Common Technical… Read More

The Importance of Food Recall Readiness

Product recalls are a fact of life in the food industry. Recalls occurred an average of 12 times per week. Allergens remain the largest cause of recalls, due to mislabeling, cross-contamination or being undeclared. Large recalls of peanut products, eggs, ground beef and cantaloupe in recent years remind us of the potentially devastating impact of… Read More

Recent Blog posts

FDA’s Use Of Photography Revisited

by Joe Famiglietti, Senior Consultant Managing an FDA inspection of your establishment is a difficult task in itself, but how should you respond when the Investigator notes a potentially objectionable condition and pulls out a camera to photograph the situation. It may be the sighting of a rodent in your facility, a poor employee practice, or… Read More

Tobacco User Fees Now Payable to FDA

With the passage of the Tobacco Control Act User Fee Final Rule, 21 CFR Part 1150, domestic tobacco manufacturers as well as importers must now submit their required data for user fee assessment calculation, under the Federal Food, Drug, and Cosmetic Act, to the FDA beginning fiscal year 2015. Required information includes the number of… Read More

Food Facility Bi-annual Registration on-going!

FDA’s many new regulations to further strengthen the safety of the U.S. food supply under FSMA include the mandatory requirement for food facilities to register bi-annually. Those that do not register risk being “de-listed,” and thus unable to legally sell or import products in the U.S. Under FSMA, FDA also has the authority to audit… Read More